A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An In
about
A randomized, parallel group, double-blind study of ticagrelor compared with aspirin for prevention of vascular events in patients undergoing coronary artery bypass graft operation: Rationale and design of the Ticagrelor in CABG (TiCAB) trial: An In
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
A randomized, parallel group, ...... r in CABG (TiCAB) trial: An In
@en
A randomized, parallel group, ...... r in CABG (TiCAB) trial: An In
@nl
type
label
A randomized, parallel group, ...... r in CABG (TiCAB) trial: An In
@en
A randomized, parallel group, ...... r in CABG (TiCAB) trial: An In
@nl
prefLabel
A randomized, parallel group, ...... r in CABG (TiCAB) trial: An In
@en
A randomized, parallel group, ...... r in CABG (TiCAB) trial: An In
@nl
P2093
P50
P1476
A randomized, parallel group, ...... n Investigator-Initiated trial
@en
P2093
Adnan Kastrati
Andreas Boening
Antoinette de Waha
Bernhard C Danner
Christoph Knosalla
Dieter Hammel
Felix Schönrath
Friedrich A Schöndube
Friedrich-Wilhelm Mohr
Gerold Goerlach
P356
10.1016/J.AHJ.2016.05.017
P407
P50
P577
2016-06-18T00:00:00Z